CME Stock - CME GROUP INC.Fundamentals & Analysis

Security & Commodity Brokers, Dealers, Exchanges & Services

CME Group Overview CME Group is a global derivatives exchange and market‑infrastructure company that combines transaction fee‑based revenue with high margins and conservative financial leverage. Profitability Profile The company’s profitability profile is a standout: trailing net profit margin reached 63.4% as of 2026‑03‑31, with reported gross margin of 82.2% and operating margin of 61.6% (2023‑1

CME GROUP INC.

Security & Commodity Brokers, Dealers, Exchanges & Services
Stock Price
$264.32
$-0.46 (-0.17%)
Aug 6, 2026
Debt to Equity
12.9%
ROE
16.1%
PE Ratio
24.90
EPS (Diluted)
$11.86

Cme Group Inc (CME) Fundamental Analysis

CME Group Overview

CME Group is a global derivatives exchange and market‑infrastructure company that combines transaction fee‑based revenue with high margins and conservative financial leverage.

Profitability Profile

The company’s profitability profile is a standout: trailing net profit margin reached 63.4% as of 2026‑03‑31, with reported gross margin of 82.2% and operating margin of 61.6% (2023‑12‑31) supporting durable cash returns to the business. Operating performance has been accompanied by multi‑year earnings and per‑share growth — five‑year diluted EPS compounded at about 17.5% (five‑year EPS CAGR 0.1748) and three‑year EPS CAGR of 14.35% (0.1435) — while revenue per share has grown roughly 7.5% year‑over‑year and a five‑year revenue‑per‑share CAGR of 7.93% (0.0793), leaving recent split‑adjusted revenue per share at $18.72 and diluted EPS at $11.86 (EPS Diluted & Revenue per Share). Quality of earnings is corroborated by strong cash conversion: trailing operating cash flow is $4.42B versus TTM net income of $4.28B, and the measured free cash flow margin registers about 64.3% (Earnings Quality Analysis).

Areas of Caution

Areas of caution include sizable volatility in financing and capital‑allocation flows and growth cadence that has moderated. Financing cash flow has swung from large negative TTM values — e.g., −$48.34B at 2023‑12‑31 — to very large positive TTM inflows (peaking at $56.51B at 2025‑12‑31 and $39.41B at 2026‑03‑31), highlighting lumpy buybacks, M&A or financing actions that materially affect reported cash‑flow patterns (Strategic Capital Allocation). Revenue per share growth also hit a trough of 5.8% in 2025‑09 before recovering to 7.5%, while trailing P/E sits near the mid‑20s at 24.9x after a 2025‑06 peak of 26.6x, indicating expectations are reflected in a relatively elevated earnings multiple (Revenue & Net Income; Price-to-Earnings (PE) Ratio Trend).

Fundamentals to Watch

Key fundamentals to watch are continuing revenue‑per‑share and diluted EPS trends (stability of the current 7–18% growth range), operating cash flow versus net income and free cash flow margin, quarterly net margin trajectory, and ROE (most recent 16.1%) alongside the cadence of financing cash flows and their use (buybacks, dividends, or acquisitions) (EPS Diluted & Revenue per Share; Profit Margin Trends; Return on Equity (ROE); Strategic Capital Allocation).

Revenue and Growth

Revenue Trend

Revenue & Net Income

The foundation of business quality and long-term value creation

Revenue & Net Income Growth

CME GROUP INC.'s revenue has trended upward in recent quarters, rising from $1.65B in 2025 Q4 to $1.88B in 2026 Q1, continuing a multi-year increase from roughly $1.2–1.3B quarterly revenue in 2022 to the current higher range.

Net income has shown more quarter-to-quarter variability; after a peak of $1.21B in 2025 Q4 it declined to $1.15B in 2026 Q1, though net income has generally increased from the sub-$700M range in late 2022 to above $900M–$1.2B in 2023–2025.

Looking across the full series, both revenue and net income are materially higher in 2023–2026 than in 2018–2021, with intermittent quarters of stronger and weaker profitability.

  • Most recent quarterly revenue: $1.88B
  • Most recent quarterly net income: $1.15B

Why Growth Matters

Consistent revenue and earnings growth are the lifeblood of successful long-term investments. Companies that can grow their top line (revenue) and bottom line (net income) over many years demonstrate they have products or services customers value and are willing to pay for repeatedly.

Revenue Growth shows whether the company is expanding its market reach, gaining market share, or successfully launching new products.Net Income Growth demonstrates the company can convert that revenue into actual profits while managing costs effectively.

Look for steady, sustainable growth rather than erratic spikes. The best businesses compound earnings year after year, creating tremendous value for shareholders over time. Companies that can grow earnings faster than revenue are improving their profitability—a sign of operational excellence and competitive strength.

CME GROUP INC. (CME) quarterly revenue and net income trend analysis showing historical financial performance over multiple years. Interactive chart displaying revenue growth, net income trends, and profitability patterns for CME stock with quarterly and annual data points.

EPS Diluted & Revenue per Share

Per-share earnings and revenue — the shareholder's view of growth

Why Per-Share Metrics Matter

Total revenue and net income can grow simply because a company issues more shares or makes acquisitions. Per-share metrics cut through that noise — they show how much value each single share of stock is generating, which is what actually matters to shareholders.

Revenue per Share (split-adjusted) tells you how much revenue the business generates for every share outstanding. Growing revenue per share means the company is either expanding the business or shrinking the share count — both shareholder-friendly signals.EPS Diluted (split-adjusted) captures bottom-line earnings per share after accounting for all dilutive instruments such as stock options and convertible debt.

The most powerful signal is when both lines rise together over many years. If revenue per share grows but EPS lags, margins are being squeezed. If EPS grows faster than revenue per share, the company is becoming more profitable — a hallmark of businesses with durable competitive advantages. Watch for share buybacks, which can mechanically lift EPS even if total earnings are flat.

CME GROUP INC. (CME) EPS diluted and revenue per share trend showing historical per-share earnings and revenue performance over time.

Revenue & EPS Growth

Year-over-year growth rates for revenue and earnings per share

Reading the Growth Rate Chart

This chart converts the absolute per-share figures into year-over-year percentage changes, making it easy to see whether growth is accelerating, decelerating, or reverting to trend — regardless of the company's absolute size.

Revenue per Share Growth (1-year, split-adjusted) measures how quickly the top line is expanding on a per-share basis. Sustained positive growth signals that the company continues to win customers and grow its addressable market.EPS Diluted Growth (1-year, split-adjusted) measures how quickly earnings are compounding for each shareholder. When EPS growth consistently outpaces revenue growth, operating leverage and margin expansion are at work.

Look for consistency, not just magnitude. A company that reliably grows EPS 10–15% per year is far more valuable than one that alternates between 50% spikes and deep contractions. Negative EPS growth during a period of positive revenue growth is a red flag — costs are rising faster than sales. Quarters where both lines converge near zero or go negative deserve close scrutiny.

CME GROUP INC. (CME) year-over-year revenue per share and EPS diluted growth rate trend analysis showing historical growth performance.

Revenue Analysis

Revenue Waterfall Analysis

How revenue converts to net income for the most recent annual period

CME GROUP INC. (CME) revenue waterfall chart showing the breakdown from total revenue to net income. Displays cost of goods sold, operating expenses, selling and administrative costs, research and development expenses, tax expenses, and final net income for CME. Annual financial statement waterfall analysis showing profit margin components and expense structure.

Period Information

Report Type: Annual (10-K)

Period: Apr 2025 to Mar 2026

Revenue Sources

Revenue composition by disclosure category for the latest period

Revenue Streams

CME generates revenue from multiple sources including derivatives exchange trading fees and related revenues from offering listed futures and options across various asset classes on CME, CBOT, NYMEX, and COMEX.

Derivatives Trading and Clearing

Fees received from clearing firms for clearing and settlement services provided by the derivatives clearing house for exchange-traded futures, options, swaps, and OTC derivatives.

Cash Markets Trading

Transaction revenues from BrokerTec and EBS for electronic trading of interest rates, money markets, repo, spot and OTC foreign exchange, and precious metals.

Market Data and Analytics

Revenue from distribution of proprietary real-time, historical, and derived market data, cash markets pricing, third-party data sets, and analytical tools via data platforms and third-party distribution partners.

Licensing and Index-Related Revenues

Income from acting as distributor, licensor, and licensing agent for benchmark indices and proprietary reference rates, including licensing arrangements with third-party index owners and joint ventures.

Ancillary Revenue

Additional revenues tied to platform services such as industry research, market education tools, and platform functionalities for order entry, execution, and risk management.

Customer Profile

  • Professional traders and financial institutions.
  • Institutional and individual investors.
  • Major corporations, manufacturers, and producers.
  • Governments and central banks.
  • Banks and non-bank professional trading firms participating in cash fixed income, repo, and FX markets.
  • Clearing firms executing and clearing trades for their customers.
  • Channel partners and third parties consuming or distributing market data, including independent software vendors and regulatory reporting and data distributors.

Geographic Reach

  • Global product and service distribution across major financial centers via international telecommunications hubs.
  • Trading and clearing of various asset classes serving multiple regions, including expansion into the Middle East with an office in Dubai.
  • Cash markets coverage includes U.S. Treasuries, European government bonds, repo markets across the EU, UK, U.S., and other G10 governments, as well as emerging market fixed income instruments and supranational bonds.
  • Global FX trading across major and emerging currencies and spot precious metals.

Distribution & Sales Channels

  • Electronic trading via CME Globex and other platforms.
  • Open outcry trading for select products in Chicago.
  • Privately negotiated trades and request-for-quote trading via BrokerTec Quote, alongside relationship-based trading through EBS Direct.
  • Front-end and workflow platforms including CME Direct and CME Direct Mobile for trading, recording, and risk management.
  • Integration with vendor systems through open APIs, and connectivity with major independent software vendors for order entry and post-trade workflows.
  • Distribution through third-party and channel partners, including independent software vendors, FCMs, IBs, broker-dealers, regulatory reporting, and data distributors.
  • Licensing and joint venture arrangements with index owners and partners for index-based products and benchmarks.

Recurring vs Transactional Revenue Characteristics

  • Clearing and transaction fees are transaction-based, assessed for trades executed and cleared on behalf of customers.
  • Market data and benchmark distribution revenues derive from real-time, historical, and derived data provided through data platforms and third-party distributors.
  • Licensing arrangements involve ongoing contractual relationships with revenue sharing obligations specified in agreements.
  • Certain cash market products are cleared through third-party clearing houses, indicating transaction-linked clearing flows.

Key Dependencies or Concentration Risks

  • Dependence on clearing firms for clearing and transaction fee revenue, and on their continued participation and trading activity.
  • Reliance on third-party distribution and channel partners, including independent software vendors, to facilitate trading and data distribution.
  • Some BrokerTec products depend on third-party clearing houses.
  • Material dependency on licensing agreements and revenue-share arrangements with third-party index owners and joint ventures for product listings.
  • Dependence on third-party technology and infrastructure providers, including a strategic partnership with a major cloud provider for core application support.
  • Customer access rights and fee structures are influenced by exchange membership, trading privileges, and protections.

Profitability

Profit Margins

Earnings Quality

Earnings Quality Analysis

Comparing reported earnings to actual cash generation

Earnings Quality Analysis — Net Income vs Operating Cash Flow (TTM)

CME GROUP INC.’s trailing twelve‑month operating cash flow and net income show a multi‑year upward trend from roughly the low‑$2 billion range in 2020–2021 to the low‑$4 billion range by 2025–2026. Both metrics have generally moved higher each year, with a notable historical divergence in 2018 where reported net income spiked above cash flow; from 2020 onward the two series exhibit steadier, more parallel growth.

In the most recent quarters the company’s operating cash flow has consistently exceeded net income on a TTM basis, with the cash‑flow premium peaking in mid‑2025 and narrowing into early 2026. The latest TTM operating cash flow was $4.42B and the latest TTM net income was $4.28B.

The Earnings vs. Cash Flow Gap

Reported earnings (Net Income) doesn't always reflect actual cash generation. Companies use accrual accounting, which recognizes revenue when earned and expenses when incurred—not when cash actually changes hands. This creates timing differences and opportunities for accounting discretion that can mask underlying business health.

Net Income (the "earnings" number) can be influenced by non-cash items like depreciation, stock-based compensation, and changes in accounting estimates.Operating Cash Flow, however, shows the actual cash the business generates from its core operations—a harder number to manipulate.

What to Look For

  • Consistent Alignment: High-quality earnings show operating cash flow tracking closely with or exceeding net income over time. This indicates the company is actually collecting cash from its reported profits.
  • Warning Sign - Divergence: If net income consistently exceeds cash flow, the company may be reporting earnings that aren't translating to cash. This could indicate aggressive revenue recognition, growing receivables that may not be collected, or inventory building up.
  • Positive Sign - Cash Exceeds Earnings: When cash flow exceeds net income, it often reflects conservative accounting (like accelerated depreciation) or strong working capital management. This is generally a sign of high earnings quality.
  • Quarterly Volatility is Normal: Some variation is expected due to timing of collections, seasonal factors, and one-time items. Focus on the trend over multiple quarters rather than any single period.

Key Insight: Companies with durable competitive advantages typically show operating cash flow that meets or exceeds net income over time, demonstrating they convert accounting profits into actual cash that can be returned to shareholders or reinvested in the business.

Return on Equity

Return on Equity (ROE)

Measuring management's efficiency at generating profits from shareholder capital

Return on Equity (ROE) Analysis

CME GROUP INC.'s trailing twelve-month ROE has risen in the most recent quarters, moving from 13.3% in 2025-09 to 14.2% in 2025-12 and accelerating to 16.1% in 2026-03. This pickup follows several quarters of relative stability in the low- to mid-teens (roughly 11.8%–13.5%) through 2023–2025.

Long-term Trends

Over the longer term, the series shows a climb from low single-digit ROEs in the early 2010s, a pronounced peak above 18–19% in 2017–2018, a moderation through 2019–2021, and a steady recovery beginning around 2022. The most recent ROE was 16.1%.

The Gold Standard of Profitability

Return on Equity (ROE) is a powerful measure of how effectively a company's management is using the money shareholders have invested. Calculated by dividing Net Income by Shareholders' Equity, it reveals how much profit is generated for every dollar of equity capital.

A consistently high ROE (typically above 15-20%) is often the signature of a "quality" business with a durable competitive advantage. It indicates that the company can generate high returns on its own capital, which it can then reinvest at these high rates to compound value over time.

What to Look For:

  • Consistency: Look for an ROE that is stable or rising over time. Erratic ROE can signal cyclicality or inconsistent management.
  • Quality vs. Leverage: While a high ROE is generally positive, it can sometimes be artificially inflated by high debt (leverage). Always cross-reference ROE with the company's Debt-to-Equity ratio to ensure the profitability is coming from operational excellence rather than excessive borrowing.
  • Comparison: ROE is most meaningful when compared against industry peers or the company's own historical average.
CME GROUP INC. (CME) Return on Equity (ROE) historical trend analysis. Quarterly chart showing the company's return on equity over time, reflecting management's efficiency in using shareholder capital.

Capital Allocation & Cash Flow

Capital Strategy

Strategic Capital Allocation

How the company generates and deploys its cash

Strategic Capital Allocation — Cash Flow Allocation Trend (TTM)

CME GROUP INC.'s operating cash flow on a trailing twelve-month basis has shown a steady upward trend over the past year, rising from about $3.91B at 2025-03-31 to $4.42B at 2026-03-31, indicating incremental improvement in cash generated from core operations.

Investing cash flow moved from small negative outflows through mid-2025 (e.g., -$88.8M at 2025-06-30 and -$78.4M at 2025-09-30) to positive inflows of roughly $1.50B at 2025-12-31 and $1.49B at 2026-03-31, marking a clear inflection toward net positive investing activity in the most recent TTM periods.

Financing cash flow has been highly volatile over the multi-year history, swinging from large negative TTM values in 2023 and mid-2024 (for example, -$48.34B at 2023-12-31 and -$37.20B at 2024-03-31) to sizable positive inflows through 2021–2022 and into 2025. In the most recent quarters, financing peaked at $56.51B at 2025-12-31 before declining to $39.41B at 2026-03-31.

The most recent trailing twelve-month values were: operating cash flow $4.42B, investing cash flow $1.49B, and financing cash flow $39.41B.

Understanding Company Strategy

Capital allocation refers to how management decides to spend and invest the company's cash. Analyzing the three primary categories of cash flow reveals a company's true operational strategy:

  • Operating Cash Flow: The engine of the business. This shows how much cash is generated from core operations. Sustainable businesses should ideally fund their growth and shareholder returns primarily from this source.
  • Investing Cash Flow: The future of the business. This includes spending on new equipment, R&D, and acquisitions. Consistent negative values are normal for growing companies as they reinvest in their future.
  • Financing Cash Flow: The funding of the business. This reflects capital raising (issuing stock or debt) versus returning capital to shareholders (dividends and buybacks) or repaying debt.

What to look for: Is the company bootstrapping (funding growth solely from operating cash)? Are they borrowing to fund aggressive expansion or dividends? Or are they capital raising by issuing new shares, potentially diluting your ownership? A healthy, mature company typically generates strong operating cash, moderately invests in growth, and returns the surplus to shareholders through financing activities.

CME GROUP INC. (CME) cash flow allocation analysis. Quarterly chart displaying the three pillars of cash flow: net cash from operating activities, investing activities, and financing activities, providing insight into the company's capital allocation strategy.

Balance Sheet

Book Value per Share

Book Value per Share

Net assets attributable to each share — the accounting floor of intrinsic value

Why Book Value per Share Matters

Book value per share is the net worth of the company — total assets minus total liabilities — divided by shares outstanding (split-adjusted). It represents the theoretical liquidation value per share if every asset were sold and every liability repaid at balance-sheet carrying values. It is the accounting foundation upon which much of equity valuation is built.

A steadily rising book value per share is one of the most reliable signals of compounding wealth creation. It means the company is retaining earnings and building net worth faster than it is returning capital or eroding it. Warren Buffett famously tracked Berkshire Hathaway's book value per share for decades as his primary measure of intrinsic value growth.

Context is essential. Asset-heavy businesses (banks, manufacturers, utilities) should be judged by book value more directly than asset-light businesses (software, consumer brands), where intangible assets like intellectual property and customer loyalty may far exceed their balance-sheet carrying values. A company trading at a large premium to book value is not necessarily overvalued — it may simply possess competitive advantages that accounting rules do not capture. Conversely, a declining book value per share — especially over multiple years — is a serious warning sign of capital destruction.

CME GROUP INC. (CME) book value per share trend showing historical net asset value per share over time, split-adjusted.

Debt to Equity

Debt-to-Equity Ratio

How much of the company is financed by debt versus shareholders' equity

Reading the Debt-to-Equity Ratio

The debt-to-equity (D/E) ratio compares total financial debt to shareholders' equity. A ratio of 1.0 means the company has borrowed one dollar for every dollar of equity; a ratio of 2.0 means it has borrowed twice as much as it owns. Financial leverage amplifies both returns and risk: in good times, debt turbocharges equity returns; in bad times, it accelerates losses and can threaten solvency.

Trends matter more than a single number. A rising D/E ratio can mean the company is taking on debt to fund growth — potentially value-creating if returns exceed the cost of capital. But it can also mean equity is being eroded through losses or that the business is borrowing simply to sustain operations. A falling D/E ratio generally reflects strengthening financial health: earnings are being retained, debt maturities are being paid down, or both.

Industry norms vary enormously. Capital-intensive sectors (utilities, real estate, financials) routinely carry high D/E ratios that would be alarming in, say, a technology company. Always compare against sector peers. As a rough rule of thumb, a D/E above 2× in a cyclical business warrants careful scrutiny of interest coverage and refinancing risk.

CME GROUP INC. (CME) debt-to-equity ratio trend showing the historical balance between financial leverage and shareholders' equity.

Current Ratio

Current Ratio

Short-term liquidity — can the company cover its near-term obligations?

Liquidity: Can the Business Pay Its Bills?

The current ratio is calculated as current assets divided by current liabilities. A ratio of 1.5 means the company has $1.50 of short-term assets — cash, receivables, inventory — for every $1.00 of obligations due within the next twelve months. It is the most direct measure of near-term financial resilience: can the business meet its obligations without needing to raise new capital or sell long-term assets at a discount?

A ratio above 1.0 is generally healthy, meaning current assets exceed current liabilities. A ratio consistently above 2.0 may indicate the company is holding excess cash or inventory that could be deployed more productively. A ratio below 1.0 is a warning sign — the company is relying on future cash generation or external financing to cover its near-term obligations, which is manageable in normal conditions but dangerous during a downturn.

Trends and context matter.A declining current ratio isn't always alarming — highly efficient businesses (e.g., large retailers with reliable daily cash flows) often run leaner balance sheets intentionally. Conversely, a rapidly rising current ratio can signal slowing sales causing inventory to build, or customers taking longer to pay. Always compare the trend against industry peers and cross-reference with the cash flow statement to assess whether the business is genuinely liquid or just holding non-cash current assets.

CME GROUP INC. (CME) current ratio trend showing the ratio of current assets to current liabilities over time, a measure of short-term liquidity.

Valuation

PE Ratio

Price-to-Earnings (PE) Ratio Trend

How much the market is paying for each dollar of company earnings

Price-to-Earnings (PE) Ratio

CME GROUP INC.'s trailing twelve-month price-to-earnings ratio moved lower into mid-2024, hitting a trough of 21.3x for the quarter ending 2024-06, then recovered through 2025 to a peak of 26.6x in 2025-06 before easing slightly in late 2025. The series from 2024-03 (23.9x) through 2026-03 (24.9x) shows a rebound from the mid-2024 low and relatively modest volatility around the mid-20x level over the most recent eight quarters.

Viewed across the longer history, the PE has had higher spikes (notably 40.0x in 2021-06 and readings near the high 30s in 2019–2021) and lower readings earlier in the decade (a low of 9.8x in 2011-12). The most recent Price-to-Earnings (P/E) ratio was 24.9x.

What Is the PE Ratio?

The Price-to-Earnings (PE) ratio is one of the most widely used valuation metrics in investing. It divides the current stock price by the company's earnings per share (EPS), revealing how much investors are willing to pay for each dollar of earnings. A high PE can signal that the market expects strong future growth, while a low PE may suggest undervaluation—or reflect genuine concerns about the company's prospects.

Context matters:PE ratios vary significantly across industries. High-growth technology companies routinely trade at PE ratios above 30x or 40x, while mature, low-growth sectors like utilities or financials often trade closer to 10–15x. Always compare a company's PE to its own history and its industry peers, not just an absolute number.

What to Look For:

  • Expanding PE (Re-rating):If the PE is rising while earnings are also growing, the market is assigning increasing confidence in the company's future. If PE rises while earnings stagnate, it may signal speculative excess.
  • Contracting PE (De-rating): A falling PE can indicate the market is losing confidence in growth prospects. If earnings grow but the PE shrinks, total returns may be muted.
  • Negative PE: When a company is loss-making, the PE ratio is negative or undefined. In these cases, investors typically use other metrics such as Price-to-Sales (P/S) or EV/EBITDA.
  • Spikes and Troughs: Sudden PE spikes often occur when earnings temporarily collapse (making the divisor small) rather than when the stock price surges. Context is key.

Key Insight:The PE ratio is a snapshot of market sentiment and expectations. Tracking it over time alongside earnings trends reveals whether the market's valuation has expanded or contracted—and whether that change is justified by fundamentals.

CME GROUP INC. (CME) Price-to-Earnings (PE) ratio historical trend analysis. Quarterly chart showing how the market has valued the company's earnings over time.